Glial fibrillary acidic protein (GFAP), the signature intermediate filament of astrocytes, has been proposed as a potential biomarker in various neurodegenerative disorders including Alzheimer’s disease [80]. The gene discussed is GFAP; the disease is early-onset autosomal dominant Alzheimer disease.